OrbiMed Capital GP V LLC insider trades
OrbiMed Capital GP V LLC has filed 6 Form 4s with the SEC that we hold, for Corvus Pharmaceuticals, Inc. (CRVS) (Director, 10% owner), PMV Pharmaceuticals, Inc. (PMVP) (10% owner), Compass Therapeutics, Inc. (CMPX) (Director, 10% owner) and TCDA (Director, 10% owner). Across all of them we count 3 purchases worth $197.3K and 3 sales worth $8.7M reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($1.5M). The largest single trade was a sale of 1,109,644 shares of Corvus Pharmaceuticals, Inc. worth $6.8M, dated 2021-09-20. The first filing on our record is dated 2021-09-22 and the latest 2025-10-27.
Corvus Pharmaceuticals, Inc. (CRVS)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-09-20 | S, sale reported on Form 4 | 1,109,644 | $6.8M | 2021-09-22 |
PMV Pharmaceuticals, Inc. (PMVP)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-05-26 | S, sale reported on Form 4 | 26,253 | $418.2K | 2022-05-31 |
| 2025-10-23 | S, sale reported on Form 4 | 1,000,000 | $1.5M | 2025-10-27 |
Compass Therapeutics, Inc. (CMPX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-05-06 | P, purchase reported on Form 4 | 10,200 | $16.6K | 2022-05-10 |
| 2022-05-09 | P, purchase reported on Form 4 | 90,712 | $141.5K | 2022-05-10 |
| 2022-05-10 | P, purchase reported on Form 4 | 24,447 | $39.1K | 2022-05-10 |
TCDA
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1615374) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms